1 / 31

Optimizing Anemia Management in Dialysis: Insights from 12 Countries

This study delves into anemia management practices and outcomes in dialysis patients across 12 countries. From erythropoiesis-stimulating agent dosing to predictors of hemoglobin levels, the study sheds light on patient and facility characteristics affecting anemia treatment efficacy. The results uncover country-specific trends in Epo dosing and Hgb concentrations, highlighting the importance of individualized care. The study also explores the impact of IV iron therapy and iron deficiency indicators on patient outcomes. Overall, this comprehensive analysis provides valuable insights for enhancing anemia management in dialysis settings globally.

yama
Télécharger la présentation

Optimizing Anemia Management in Dialysis: Insights from 12 Countries

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. Anemia Management and Outcomes from 12 Countriesin the Dialysis Outcomes and Practice Patterns Study (DOPPS)

  4. Introduction (1)

  5. Introduction (2)

  6. DOPPS Background

  7. Methods: Study Sample

  8. Methods: Descriptive Statistics

  9. Methods: Hgb and Outcomes

  10. Methods: Epo Dosing

  11. Methods: Predictors of Hgb >11 g/dl and of Epo Use

  12. Epo Use and Hgb Concentrations for Prevalent Patients

  13. Patients New to ESRD: Mean Hgb and Pre-ESRD Epo Use

  14. Patient-Level Characteristics1 Associated with Hgb  11g/dl, 2002-03

  15. Facility-Level Characteristics1 Associated with Hgb  11g/dl, 2002-03

  16. Epo Dose by Country, 2002-2003

  17. Mean Epo Dose and Odds of Hgb >11 g/dl by Country, 2002-03

  18. Patient Characteristics Associated with Receiving Higher Weekly Epo Dose, 2002-03 (1)

  19. Patient Characteristics Associated with Receiving Higher Weekly Epo Dose, 2002-03 (2)

  20. Relative Risk of Mortality by Hgb Group, 1996-2001

  21. Relative Risk of Hospitalization by Hgb Group, 1996-2001

  22. Unadjusted Weekly Epo Dose and Mean Hgb by Country, 2002-2003

  23. Percentage of Epo-treated Patients Receiving Epo by Intravenous Route in 2002 vs. 2003

  24. Indicators of Iron Deficiency and Intravenous Iron Therapy, by Country, 2002-03

  25. Unadjusted Hospitalization Rates by Country, 1996-2001

  26. Results (1)

  27. Results (2)

  28. Results (3)

  29. Conclusions

  30. Acknowledgements

More Related